We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma.
- Authors
Yoshimizu, Shoichi; Kawachi, Hiroshi; Yamamoto, Yorimasa; Nakano, Kaoru; Horiuchi, Yusuke; Ishiyama, Akiyoshi; Tsuchida, Tomohiro; Yoshio, Toshiyuki; Hirasawa, Toshiaki; Ito, Hiromichi; Fujisaki, Junko
- Abstract
Background: Management strategies for primary non-ampullary duodenal adenocarcinoma (NADAC) in early stage are not well established given its low incidence. This study aimed to elucidate clinicopathological features of early NADAC, including risk for lymph nodal metastasis (LNM). Methods: In total, 166 patients with early NADAC underwent initial treatment at our institution between 2006 and 2019, of whom 153 had intramucosal (M-) and 13 had submucosal (SM-) NADAC. These endoscopic and pathological features were retrospectively analyzed. Risk factors for LNM were evaluated in 46 early NADAC patients who underwent surgery with lymph node dissection. Results: Compared with M-NADAC, SM-NADAC was significantly more frequently located at the proximal side of the papilla, with mixed elevated and depressed macroscopic type, histologically poorly differentiated tumor and lymphovascular invasion (LVI) (85% vs. 47%, P = 0.009; 54% vs. 5%, P < 0.001; 23% vs. 0%, P < 0.001; and 46% vs. 0%, P < 0.001, respectively). The frequency of LNM was significantly higher in SM-NADAC than in M-NADAC (5/12, 42% vs. 0/34, 0%; P < 0.001). In SM-NADAC, the frequency of LNM was higher in poorly differentiated than in well to moderately differentiated tumors (3/3, 100% vs. 2/9, 22%) and higher in tumors with LVI than in those without LVI (3/5, 60% vs. 2/7, 29%). Regarding invasion depth, 2 of 4 patients with SM invasion (400 ≤ × < 500 µm) showed LNM. However, in this study, no patients developed very shallow SM invasion (0 < × < 400 µm). Conclusions: SM-NADAC showed high LNM risk. Surgical treatment with regional lymph node dissection is recommended as a treatment strategy for SM-NADAC.
- Subjects
DUODENAL tumors; LYMPH nodes; LYMPHADENECTOMY; LYMPH node surgery; METASTASIS
- Publication
Journal of Gastroenterology, 2020, Vol 55, Issue 8, p754
- ISSN
0944-1174
- Publication type
Article
- DOI
10.1007/s00535-020-01696-6